Upper Gastrointestinal Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, St Leonards Sydney New South Wales Australia.
Discipline of Surgery, Northern Clinical School, University of Sydney Sydney New South Wales Australia.
BJS Open. 2019 Mar 18;3(4):521-531. doi: 10.1002/bjs5.50154. eCollection 2019 Aug.
There are concerns that non-anatomical resection (NAR) worsens perioperative and oncological outcomes compared with those following anatomical resection (AR) for colorectal liver metastases (CRLM). Most previous studies have been biased by the effect of tumour size. The aim of this study was to compare oncological outcomes after NAR AR.
This was a retrospective study of consecutive patients who underwent CRLM resection with curative intent from 1999 to 2016. Data were retrieved from a prospectively developed database. Survival and perioperative outcomes for NAR and AR were compared using propensity score analyses.
Some 358 patients were included in the study. Median follow-up was 34 (i.q.r. 16-68) months. NAR was associated with significantly less morbidity compared with AR (31·1 44·4 per cent respectively; = 0·037). Larger (hazard ratio (HR) for lesions 5 cm or greater 1·81, 95 per cent c.i. 1·13 to 2·90; = 0·035) or multiple (HR 1·48, 1·03 to 2·12; = 0·035) metastases were associated with poor overall survival (OS). Synchronous (HR 1·33, 1·01 to 1·77; = 0·045) and multiple (HR 1·51, 1·14 to 2·00; = 0·004) liver metastases, major complications after liver resection (HR 1·49, 1·05 to 2·11; = 0·026) or complications after resection of the primary colorectal tumour (HR 1·51, 1·01 to 2·26; = 0·045) were associated with poor disease-free survival (DFS). AR was prognostic for poor OS only in tumours smaller than 30 mm, and R1 margin status was not prognostic for either OS or DFS. NAR was associated with a higher rate of salvage resection than AR following intrahepatic recurrence.
NAR has at least equivalent oncological outcomes to AR while proving to be safer. NAR should therefore be the primary surgical approach to CRLM, especially for lesions smaller than 30 mm.
有观点认为,与解剖性肝切除术(AR)相比,非解剖性肝切除术(NAR)会导致结直肠癌肝转移(CRLM)患者的围手术期和肿瘤学结果恶化。大多数既往研究都受到肿瘤大小影响的偏差。本研究旨在比较 NAR 和 AR 后的肿瘤学结果。
这是一项回顾性研究,纳入了 1999 年至 2016 年间接受以治愈为目的的 CRLM 切除术的连续患者。数据来自一个前瞻性开发的数据库。使用倾向评分分析比较 NAR 和 AR 的生存和围手术期结果。
研究纳入了 358 名患者。中位随访时间为 34(IQR 16-68)个月。与 AR 相比,NAR 的发病率显著降低(分别为 31.1%和 44.4%; = 0.037)。病变直径为 5cm 或更大(危险比(HR)为 1.81,95%置信区间(CI)为 1.13 至 2.90; = 0.035)或多发病灶(HR 为 1.48,1.03 至 2.12; = 0.035)与总体生存(OS)不良相关。同步(HR 为 1.33,1.01 至 1.77; = 0.045)和多发病灶(HR 为 1.51,1.14 至 2.00; = 0.004)、肝切除术后主要并发症(HR 为 1.49,1.05 至 2.11; = 0.026)或结直肠原发肿瘤切除术后并发症(HR 为 1.51,1.01 至 2.26; = 0.045)与无病生存(DFS)不良相关。AR 仅在肿瘤小于 30mm 时对 OS 预后不良,而切缘状态对 OS 或 DFS 均无预后意义。NAR 与 AR 相比,肝内复发后挽救性切除术的比例更高。
NAR 的肿瘤学结果至少与 AR 相当,同时安全性更高。因此,NAR 应该是 CRLM 的主要手术方法,特别是对于直径小于 30mm 的病灶。